ATCIP___Antimicrobial_Therapy_in_Immunocompromised_and_Critically_Ill_Patients__
ATCIP___Antimicrobial_Therapy_in_Immunocompromised_and_Critically_Ill_Patients__
01/06/2023 - 02/06/2023
ATCIP - Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives
In-person Registrations close on 26/05/2023

Date and time

TITLE

01/06/2023 - 02/06/2023

In-person

Registration Fees
Nurses
01/06/2023 - 02/06/2023

In-person

Registration Fee until 15/04/2023 € 150,00

Physicians, PhD, other academics
01/06/2023 - 02/06/2023

In-person

Registration Fee until 15/04/2023 € 250,00

Resident Physicians, Postdoctoral students
01/06/2023 - 02/06/2023

In-person

Registration Fee until 15/04/2023 € 100,00

Students
01/06/2023 - 02/06/2023

In-person

Registration Fee until 15/04/2023 € 50,00

The aim of ATCIP 2023 is to provide practical, updated
information on the management of infectious diseases
and the most appropriate antimicrobial therapy in
immunocompromised and critically ill patients.
Brief talks given by international experts will provide
insight into research and therapy of infectious diseases
during plenary sessions and an interactive session. New
rapid diagnostic tools and their utility for the clinician
will be discussed. Infectious complications in transplant
patients and the corresponding therapeutic approaches
will be reviewed in a dedicated session, as will infections
related to the use of immunosuppressive agents in
oncology patients. New therapeutic approaches to treat
ventilator-associated pneumonia and infections after
abdominal surgery and recent treatment approaches for
HIV will be the theme of dedicated sessions. Advances in
the diagnosis of fungal pathogens, methods to tackle the
occurrence of invasive aspergillosis in the ICU, and new
treatment options against known and emerging invasive
fungal diseases will be discussed. A poster session will
allow participants to exchange information and to discuss
common problems.